Comparing Surgical and Nonsurgical Outcomes of Tennis Elbow
Nonoperative vs. Surgical Release for Acute-to-Subacute Lateral Epicondylitis: A Prospective Randomized Controlled Trial
1 other identifier
interventional
200
1 country
1
Brief Summary
Tennis elbow is a condition that causes pain on the outside of the elbow, typically caused by motions involving straightening of the arm. The goal of this clinical trial is to investigate whether early surgery leads to better outcomes than physical therapy and watchful waiting for tennis elbow (lateral epicondylitis) in adults. This study aims to answer the following questions:
- Does earlier surgical intervention improve pain and function more than physical therapy and watchful waiting after one year?
- How do symptoms and function compare between the two treatments over two years?
- How often do people who start with physical therapy and watchful waiting end up needing surgery? Researchers will compare early surgery to physical therapy and watchful waiting to see which treatment works better. Participants will...
- be randomly assigned to have surgery or to try physical therapy and watchful waiting.
- have a physical exam and grip strength test at each visit.
- answer questionnaires about their elbow pain and function.
- attend appointments at the start of the study, and at 6 weeks, 3 months, 6 months, 1 year, and 2 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedFirst Posted
Study publicly available on registry
October 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 15, 2030
October 21, 2026
October 1, 2026
2 years
September 8, 2026
October 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Patient-Rated Tennis Elbow Evaluation (PRTEE) from baseline to 1 year
0 indicates no pain and no disability; 100 indicates worst imaginable pain and significant functional deficit; "change" refers to differences between each timepoint and the baseline, as well as the differences between each consecutive timepoint
Baseline, 6 weeks, 3 months, 6 months, 1 year
Secondary Outcomes (13)
Change in Patient-Rated Tennis Elbow Evaluation (PRTEE) at All Other Timepoints
Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years
Change in Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) at Each Timepoint; "change" refers to differences between each timepoint and the baseline, as well as the differences between each consecutive timepoint
Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years
Grip Strength
Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years
Conversion Rate
Baseline to 2 years after baseline
Patient Satisfaction (5-Point Likert Scale)
Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years
- +8 more secondary outcomes
Study Arms (2)
Surgical
EXPERIMENTALSurgical management of lateral epicondylitis
Conservative
ACTIVE COMPARATORConservative management of lateral epicondylitis with option to convert to surgical management
Interventions
* Formal physical therapy: eccentric strengthening and stretching program for the wrist extensor musculature, supervised by a licensed physical therapist, for a minimum of 6 weeks * Activity modification counseling: avoidance of repetitive wrist extension, gripping, and forearm rotation activities that reproduce symptoms * Counterforce (lateral epicondyle) bracing during symptomatic activities * NSAIDs or topical anti-inflammatory agents
Patients randomized to surgery will undergo operative release and debridement of the common extensor origin within 6 weeks of enrollment. Surgical technique will be at the attending surgeon's discretion and may include open release and debridement of the ECRB, percutaneous release, or arthroscopic release and debridement. Surgical technique will be recorded as a covariate. All surgeries will be performed by fellowship-trained hand and upper extremity surgeons within the Surgery of the Upper Extremity Research (SUPER) Group. Postoperative rehabilitation protocols will follow standard institutional practice and will be recorded.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of lateral epicondylitis, defined by:
- Lateral elbow pain reproduced by resisted wrist extension or resisted middle finger extension
- Tenderness to palpation over the lateral epicondyle or common extensor origin
- Symptom duration of at least 2 weeks and no more than 3 months at time of enrollment
- Willing and able to comply with follow-up schedule and assigned treatment protocol
- Able to provide written informed consent
You may not qualify if:
- Prior surgery on the ipsilateral elbow
- Prior corticosteroid or biologic (PRP, autologous blood) injection to the ipsilateral lateral epicondyle within 3 months of enrollment
- Concomitant ipsilateral elbow pathology (e.g., posterolateral rotatory instability, radial tunnel syndrome, intra-articular pathology, medial epicondylitis)
- Cervical radiculopathy or other proximal source of referred lateral elbow pain
- Active elbow fracture or acute traumatic injury to the affected extremity
- Inflammatory arthropathy affecting the elbow (e.g., rheumatoid arthritis, gout)
- Pregnancy
- Inability to comply with follow-up visits or complete patient-reported outcome instruments
- Concurrent participation in another interventional study affecting upper extremity function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UPMC
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John R Fowler, MD
University of Pittsburgh Medical Center
- STUDY DIRECTOR
John R Fowler, MD
University of Pittsburgh Medical Center
- STUDY CHAIR
John R Fowler, MD
University of Pittsburgh Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 8, 2026
First Posted
October 21, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
September 15, 2028
Study Completion (Estimated)
September 15, 2030
Last Updated
October 21, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared with outside researchers to preserve participant privacy and confidentiality.